Related Experiment Video
Updated: Aug 1, 2025

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
Published on: March 31, 2022
Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study
Christina König1,2, Jens Martens-Lobenhoffer3, Patrick Czorlich4
1Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Background:
For treatment of ventriculitis, vancomycin and meropenem are frequently used as empiric treatment but cerebrospinal fluid (CSF) penetration is highly variable and may result in subtherapeutic concentrations. Fosfomycin has been suggested for combination antibiotic therapy, but data are sparse, so far. Therefore, we studied CSF penetration of fosfomycin in ventriculitis.
Methods:
Adult patients receiving a continuous infusion of fosfomycin (1 g/h) for the treatment of ventriculitis were included. Routine therapeutic drug monitoring (TDM) of fosfomycin in serum and CSF was performed with subsequent dose adaptions. Demographic and routine laboratory data including serum and CSF concentrations for fosfomycin were collected. Antibiotic CSF penetration ratio as well as basic pharmacokinetic parameters were investigated.
Results:
Seventeen patients with 43 CSF/serum pairs were included. Median fosfomycin serum concentration was 200 [159-289] mg/L and the CSF concentration 99 [66-144] mg/L. Considering only the first measurements in each patient before a possible dose adaption, serum and CSF concentrations were 209 [163-438] mg/L and 104 [65-269] mg/L. Median CSF penetration was 46 [36-59]% resulting in 98% of CSF levels above the susceptibility breakpoint of 32 mg/L.
Conclusion:
Penetration of fosfomycin into the CSF is high, reliably leading to appropriate concentrations for the treatment of gram positive and negative bacteria. Moreover, continuous administration of fosfomycin appears to be a reasonable approach for antibiotic combination therapy in patients suffering from ventriculitis. Further studies are needed to evaluate the impact on outcome parameters.
Insights
Fosfomycin demonstrates high cerebrospinal fluid (CSF) penetration in ventriculitis patients, achieving therapeutic concentrations. Continuous infusion of fosfomycin is a viable option for combination antibiotic therapy in treating this infection.
Area of Science:
- Pharmacology
- Infectious Diseases
- Neuroscience
Background:
- Ventriculitis treatment often uses vancomycin and meropenem, but their cerebrospinal fluid (CSF) penetration is variable, potentially leading to subtherapeutic levels.
- Fosfomycin is a potential alternative for combination therapy, yet data on its CSF penetration are limited.
Purpose of the Study:
- To investigate the CSF penetration of fosfomycin in adult patients with ventriculitis.
- To determine if continuous infusion of fosfomycin achieves adequate concentrations in the CSF for effective treatment.
Main Methods:
- Adult patients receiving continuous infusion of fosfomycin (1 g/h) for ventriculitis were enrolled.
- Therapeutic drug monitoring of fosfomycin in serum and CSF was conducted, with dose adjustments as needed.
- CSF penetration ratios and pharmacokinetic parameters were analyzed using collected laboratory data.
Main Results:
- Seventeen patients provided 43 CSF/serum samples.
- Median fosfomycin CSF concentration was 99 mg/L, with a median CSF penetration ratio of 46%.
- 98% of CSF fosfomycin levels exceeded the susceptibility breakpoint of 32 mg/L.
Conclusions:
- Fosfomycin exhibits high CSF penetration, ensuring concentrations effective against Gram-positive and Gram-negative bacteria.
- Continuous administration of fosfomycin is a promising strategy for antibiotic combination therapy in ventriculitis.
- Further research is warranted to assess the clinical outcomes associated with fosfomycin treatment for ventriculitis.
More Related Videos
06:59Intrathecal Application of a Fluorescent Dye for the Identification of Cerebrospinal Fluid Leaks in Cochlear Malformation
Published on: February 29, 2020
07:26Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
Published on: July 1, 2018
Related Concept Videos
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management